A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro

PURPOSE: The primary goal of the present study was to develop the nano-drug consisting of doxorubicin and exosome derived from mesenchymal stem cells, and to explore its effect on osteosarcoma in vitro. METHODS: The exosomes were isolated from bone marrow MSCs (BM-MSCs) by an Exosome Isolation Kit....

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Hongxiang, Chen, Jinyuan, Wang, Shenglin, Fu, Feihuan, Zhu, Xia, Wu, Chaoyang, Liu, Zhoujie, Zhong, Guangxian, Lin, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830377/
https://www.ncbi.nlm.nih.gov/pubmed/31802872
http://dx.doi.org/10.2147/IJN.S218988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830377/
https://www.ncbi.nlm.nih.gov/pubmed/31802872
http://dx.doi.org/10.2147/IJN.S218988

Ejemplares similares